AtlantiCare
en Español
 
AboutHealth ServicesHealth ConditionsLocationsEvents & CoursesCommunityWays of Giving
  Search  
 
Health News
Today's Headlines
Health Alerts
Health News Feature
Future of Medicine
Health Observances
Product Recalls
Health Library
Illnesses & Conditions
Drug Guide
FDA Drug Approvals
Medical Tests
Self-Help Resources
Complementary Medicine
Medline Search
Health Topics
Allergies
Asthma
Back Pain
Cancer
Caregiver
Depression
Diabetes
GERD
Heart
Kidney
Men's Health
Orthopedic
Parenting
Patient Safety
Pregnancy
Senior
Stress
Stroke
Weight Mgmt
Women's Health
Healthy Living
Fitness
Nutrition
Mind & Body
Family & Home
Today's Headlines

Health News
Daily articles from HealthDay News: breaking news on health issues, drug approvals and recent discoveries.

Dietary Supplement May Prevent Breast Cancer


Resveratrol, found in red wine, grape skins, inhibits abnormal cells, study finds

MONDAY, July 7 (HealthDay News) -- A compound found in red grapes and red wine suppresses abnormal cell formation that leads to most types of breast cancer, according to U.S. researchers.

The compound, resveratrol, is sold in extract form as a dietary supplement.

Breast cancer forms through a multi-stage process that differs depending on the type of disease, a person's genes, and other factors. However, it's known that increased estrogen fuels many types of breast cancer.

"Resveratrol has the ability to prevent the first step that occurs when estrogen starts the process that leads to cancer by blocking the formation of the estrogen DNA adducts. We believe that this could stop the whole progression that leads to breast cancer down the road," study author Eleanor G. Rogan, a professor in the Eppley Institute for Research in Cancer and Allied Diseases at the University of Nebraska Medical Center, said in a prepared statement.

In laboratory testing, Rogan and her team found that as little as 10 umol/L of resveratrol could suppress DNA adducts associated with breast cancer. A glass of red wine contains between 9 and 28 umol/L of resveratrol.

Rogan and colleagues also found that reseveratrol suppressed expression of CYP1B1 and the formation of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, two known risk factors for breast cancer.

Resveratrol induces an enzyme called quinone reductase, which reduces the estrogen metabolite back to inactive form and reduces breast cancer risk, Rogan explained.

The findings, which are in the July issue of Cancer Prevention Research, will have to be confirmed in human trials, she noted.

More information

The U.S. National Cancer Institute has more about breast cancer prevention.

SOURCE: American Association for Cancer Research, news release, July 7, 2008
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Health News Provided By:
HealthDay
 
 
Notice of Privacy Practices | | Disclaimer    © 2006 AtlantiCare AtlantiCare Access
 

  Powered by HEALTHvision